11 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Chart - Agents and Dosing ... Pharmacology #Opioid #Opiate ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Equianalgesic Opioid Dosing 

#Pharmacology #Pain #Opioid #Opiate #Conversion #Equianalgesic #Table
Equianalgesic Opioid Dosing ... #Pain #Opioid #Opiate ... #Conversion #Equianalgesic ... #Table
Transdermal Fentanyl require unique dosing conversions. For Adult and pediatric patients taking opiouds or doses not
require unique dosing ... conversions. ... Then using Table ... Pharmacology #Pain #Opiate ... #Opioid #Conversion
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
class is still going ... initiating an ARB ... Receptor #Blockers #ARB ... #Conversion #Table ... #Dosing #Pharmacology
Angiotensin II Receptor Blocker (ARB) - Comparable Dose Chart 
 - Valsartan (Diovan®) 40 mg daily
Receptor Blocker (ARB ... 20 mg daily #ARB ... #Equivalent #Conversion ... #Dosing #Doseage ... #Table #AngiotensinII
CA-Bridge Buprenorphine Hospital Quick Start Algorithm - Management of acute opiate withdrawal 
 - Any prescriber
Management of acute opiate ... If patient is stable ... Buprenorphine Dosing ... sublingual (SL) are ... chronic pain split dosing
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
stratification algorithm ... and rivaroxaban are ... for appropriate dosing ... pulmonary embolism; GI ... Malignancy #Cancer #Algorithm
ANGIOTENSIN II RECEPTOR ANTAGONIST (ARB) DOSING:
TOOL FOR SWITCHING BETWEEN AGENTS IN CANADA
The information provided is intended
RECEPTOR ANTAGONIST (ARB ... ) DOSING: TOOL ... #ARB #AngiotensinII ... #Pharmacology #Conversion ... Switching #Equivalent #Table
Rybelsus (oral semaglutide) - First Oral GLP-1 Agonist
Dosing:
3 mg daily x 30 days, then 7 mg
GLP-1 Agonist Dosing ... oral route by using ... drug to remain stable ... GLP1 agonists are ... known to have GI
SLE (Systemic Lupus Erythematosus)

Suspect:
Clinical evidence of (fatigue, rash, photosensitivity, inflammatory arthritis, weight loss, and fever) and
ANA, anti-Smith Ab ... Skin Disease Classification ... pericardial/abd GI ... pancreatitis, protein-losing ... and psychosis • AB